NCT03749538

Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University of Sao Paulo · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases that primarily affect the skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of acute transcranial current stimulation session in patients with systemic autoimmune myopathies.

Detailed description

Currently, there are no studies evaluating the transcranial current stimulation technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of acute transcranial direct current stimulation session in patients with systemic autoimmune myopathies.

Conditions

• Myopathy
• Neurologic Manifestations
• ElectroPhys: Myopathy

Interventions

Type	Name	Description
OTHER	Transcranial direct current stimulation session.	Patients with systemic autoimmune myopathies will receive or not acute transcranial direct current stimulation session.

Timeline

• Start date: 2018-10-01
• Primary completion: 2024-05-06
• Completion: 2024-12-04
• First posted: 2018-11-21
• Last updated: 2024-12-05

Locations

1 site across 1 country: Brazil